Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

They analyzed data from adult ED visits between January 2020 and September 2022, focusing on individuals with a primary diagnosis of acute migraine or non-specific headache who received IM or IV ...

Roy and her team have published numerous manuscripts on findings from the HeadSMART database, with the most recent being a secondary data analysis examining the “Relationship Between Posttraumatic ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Q4 2024 Earnings Call Transcript February 18, 2025 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

I’d go as far as to say that you haven’t really watched David Lynch unless you’ve done so in the wee hours of the morning, ...

Headaches can be experienced by people at different times of the day and in varying intensity. It is especially common at the ...

COVID-19. The coronaviruses that cause COVID, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS) have similar symptoms. They include headache, nausea ...

Elisabeth Hospital, Hilvarenbeekseweg 60, 5022 GC Tilburg, The Netherlands; t.yilmaz{at}elisabeth.nl Objectives To determine the prevalence and potential risk factors of acute and chronic ...

However, neurological manifestations are also being reported in the literature. The neurological features of this infection include headache, dizziness, anosmia, taste disturbances, cerebrovascular ...